Gilead Sciences to Present at the Jefferies 2019 Global Healthcare Conference on Wednesday, June 5
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Daniel O’Day, Gilead’s Chairman and Chief Executive Officer, will participate in a fireside chat at the Jefferies 2019 Global Healthcare Conference in New York on Wednesday, June 5 at 11:30 a.m. Eastern Time.
The audio portion of the fireside chat will be accessible live through the company’s Investors page at http://investors.gilead.com/ . Please connect to the company’s website at least 15 minutes prior to the start of the presentation to ensure adequate time for any software download that may be required to listen to the webcast. The replay will be available for 14 days following the presentation.
About Gilead Sciences
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
For more information on Gilead Sciences, please visit the company’s website at www.gilead.com , follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SLATE-ASSET-MANAGEMENT19.8.2019 14:02:57 CEST | Press release
Slate Asset Management Announces Minority Investment From Goldman Sachs Asset Management’s Petershill Program
CA-OPENGATE-CAPITAL19.8.2019 14:02:56 CEST | Press release
OpenGate Capital Announces Acquisition of Majority Interest in InRule Technology, Inc.
APTUM-TECHNOLOGIES19.8.2019 14:02:06 CEST | Press release
Cogeco Peer 1 Changes Name to Aptum Technologies; Adds New Services to Enhance and Expand Hybrid Cloud Offerings
ADVANTAGE-SMOLLAN19.8.2019 13:02:04 CEST | Press release
Advantage Smollan has Acquired Majority Ownership of WorkShop
PA-KNOPP-BIOSCIENCES-LLC19.8.2019 12:02:12 CEST | Press release
Knopp Biosciences Announces Start of Phase 2 Clinical Trial Evaluating Oral Dexpramipexole in Moderate-to-Severe Eosinophilic Asthma
CTA19.8.2019 09:02:03 CEST | Press release
CES Unveiled in Amsterdam to Showcase Tech for Good
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom